Exact Imaging Secures CDN $21.5 Million to Support Commercialization of Its Exactvu™ Micro-Ultrasound

Ontario Industry Updates
Written By Guest User

TORONTO, CANADA -- (January 5, 2017) Exact Imaging (www.exactimaging.com), the world’s leader in high resolution micro-ultrasound systems enabling real-time imaging and biopsy guidance for the prostate, announced it has secured CDN $21.5 million in a Series C investment to commercialize its ExactVu™ micro-ultrasound system.  The financing, which closed late in 2016, was co-led by Lumira Capital (Toronto, ON) and Vesalius Biocapital (Luxembourg) with participation from numerous new investors including PMV (Participatiemaatschappij Vlaanderen) (Brussels, Belgium) and strong support from existing investors including iGan Partners/Rowanwood Ventures (Toronto, ON).

For the full press release click here

 

Guest User
Previous

Springboard Enterprises: Applications Open for Health Innovation Hub
Next

Versant Ventures Closes 6th Healthcare Fund